These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23429825)

  • 21. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venlafaxine and treatment-resistant depression.
    Thase ME; Friedman ES; Howland RH
    Depress Anxiety; 2000; 12 Suppl 1():55-62. PubMed ID: 11098415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of lamotrigine in a resistant case of depersonalization disorder.
    Rosagro-Escámez F; Gutiérrez-Fernández N; Gómez-Merino P; de la Vega I; Carrasco JL
    Actas Esp Psiquiatr; 2011; 39(4):263-6. PubMed ID: 21769750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response relationship with venlafaxine.
    Kelsey JE
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):21S-26S; discussion 26S-28S. PubMed ID: 8784645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
    Fountoulakis KN; Iacovides A; St Kaprinis G
    Can J Psychiatry; 2004 Jan; 49(1):73-4. PubMed ID: 14763683
    [No Abstract]   [Full Text] [Related]  

  • 27. Lamotrigine augmentation in premenstrual dysphoric disorder: a case report.
    Sepede G; Martinotti G; Gambi F; Salerno RM; Di Giannantonio M
    Clin Neuropharmacol; 2013; 36(1):31-3. PubMed ID: 23334074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
    Papadimitriou GN; Theleritis CG; Papageorgiou CC; Kalogeromitros D; Syrigou E; Gregoriou S; Rabavilas AD
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1019. PubMed ID: 16922966
    [No Abstract]   [Full Text] [Related]  

  • 29. Medication-associated somnambulism.
    Lange CL
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):211-2. PubMed ID: 15725964
    [No Abstract]   [Full Text] [Related]  

  • 30. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.
    Gressier F; Ellul P; Dutech C; Ait Tayeb AEK; Monfort J; Corruble E; Becquemont L; Hardy P; Verstuyft C
    Am J Psychiatry; 2014 Aug; 171(8):890. PubMed ID: 25082493
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: venlafaxine for functional chest pain: hope or hype?
    Tutuian R
    Am J Gastroenterol; 2010 Jul; 105(7):1513-4. PubMed ID: 20606658
    [No Abstract]   [Full Text] [Related]  

  • 33. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity: randomized, double-blind, placebo-controlled study.
    Aliyev NA; Aliyev ZN
    J Clin Psychopharmacol; 2011 Feb; 31(1):61-5. PubMed ID: 21192145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
    Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
    Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venlafaxine versus fluoxetine.
    Paton C
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term treatment of geropsychiatric depressed patients with venlafaxine.
    Amore M; Ricci M; Zanardi R; Perez J; Ferrari G
    J Affect Disord; 1997 Dec; 46(3):293-6. PubMed ID: 9547127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A; Gendron A; McIntyre A
    Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.